The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens

Yi-Ying Wu(National Cheng Kung University Hospital), Tse-Ming Hong(National Cheng Kung University Hospital)
Journal of Experimental & Clinical Cancer Research
July 1, 2019
Cited by 60


Related Papers